Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ferrocene. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112010910B details a novel iridium-catalyzed synthesis of chiral ferrocene homoallylamines, offering high yields and enantioselectivity for cost-effective pharmaceutical intermediate manufacturing.
Patent CN108752174B reveals a novel dual-catalyst method for alkynone compounds. Achieve superior yields and streamlined supply chains for pharmaceutical intermediates.
Patent CN103145767A reveals a high-yield, one-pot synthesis for p-ferrocenyl benzaldehyde. Discover cost-effective manufacturing and scalable supply solutions for organometallic intermediates.
High-yield synthesis method for palladium catalyst. Reduces cost and improves supply chain reliability for pharmaceutical intermediates and fine chemical manufacturing processes.
Patent CN103641696B details one-step synthesis for high-purity ether. Offers supply chain reliability and cost reduction in polymer additive manufacturing.
Patent CN106046065B details a high-yield synthesis of chiral ferrocene ligands. Discover cost-effective manufacturing and reliable supply chain solutions for asymmetric catalysis.
Patent CN103012498A reveals high-efficiency Ir-catalysts for ketone reduction, offering scalable routes for chiral pharmaceutical intermediates.
Novel ferrocene-based PNO ligand patent CN113004341B enables high-selectivity asymmetric hydrogenation for cost-effective pharmaceutical intermediate manufacturing and supply chain stability.
Patent CN108409802B details a high-efficiency iridium-catalyzed asymmetric hydrogenation route for producing high-purity chiral ferrocene amines with significant cost advantages.
Novel side-arm ferrocene ligands enable efficient asymmetric cyclopropanation for pyrethroid production with high yield and selectivity.
Patent CN104829655A reveals novel synthesis for anticancer intermediates. Offers scalable routes and purity advantages for pharmaceutical supply chains.
Novel stable method for ferrocenylphosphine ligand synthesis offering cost reduction and supply chain reliability for asymmetric catalysis applications.
Patent CN110862421A reveals a safe 3-step synthesis avoiding hazardous reagents, ensuring high purity intermediates for reliable pharmaceutical intermediates supply chains.
Patent CN121135789A reveals a novel supramolecular catalytic route for chiral Ugi amine. Achieve 99% ee and 99% yield with scalable, cost-effective manufacturing for global supply chains.
Novel Pd-catalyzed cyclization for ferrocene piperidones. High yield, air-stable process reduces manufacturing costs for pharmaceutical intermediates.
Novel ferrocene-catalyzed route offers high yield and mild conditions for isocoumarin manufacturing ensuring supply chain stability and cost reduction in pharmaceutical intermediates manufacturing for global buyers.
Patent CN102584905B details a novel Blanc chloromethylation method. This report analyzes cost reduction in pharma intermediates manufacturing and supply chain reliability for global buyers.
Novel BF3 catalyzed route offers high yield and stability. Ideal for reliable pharmaceutical intermediates supplier seeking cost reduction.
Patent CN108774271A introduces stable ferrocene ligands for S-configuration alcohols. Enhances supply chain reliability and reduces manufacturing costs for pharma intermediates.
Novel C2 symmetric ligand enables high enantioselectivity in API intermediate manufacturing with improved stability and scalable synthesis routes.